- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03342469
Food Additives Effects on EEG Profiles in College Students With ADHD
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20007
- American University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Generally good health
- 18-24 years old
- Currently attending college
- Physician's diagnosis of ADHD (unless control participant)
- Stable medication dose and frequency for 3 months before the study
- Willing to suspend ADHD medication administration on testing day and the day after testing
Exclusion Criteria:
- Presence of comorbid psychiatric condition other than comorbid depression or anxiety
- Autism
- Severe asthma requiring past hospitalization
- Seizure disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: ADHD- Artificial food coloring, then placebo
Participants first received 225 mg of the six most common artificial food colors (Red 40, Red 3, Yellow 5, Yellow 6, Blue 1, and Blue 2) mixed in chocolate cookies and consumed consecutively over three days (Monday, Tuesday, Wednesday).
After a 4-day washout period, they then received placebo of chocolate cookies and consumed them over three days.
|
225mg mixed powdered Artificial Food Coloring (AFC)
Placebo chocolate cookies
|
|
Experimental: ADHD - Placebo, then artificial food coloring
Participants first received placebo of chocolate cookies and consumed them over three days.
After a 4-day washout period, they then received 225 mg of the six most common artificial food colors (Red 40, Red 3, Yellow 5, Yellow 6, Blue 1, and Blue 2) mixed in chocolate cookies and consumed consecutively over three days (Monday, Tuesday, Wednesday).
|
225mg mixed powdered Artificial Food Coloring (AFC)
Placebo chocolate cookies
|
|
Experimental: Controls- Artificial food coloring, then placebo
Participants first received 225 mg of the six most common artificial food colors (Red 40, Red 3, Yellow 5, Yellow 6, Blue 1, and Blue 2) mixed in chocolate cookies and consumed consecutively over three days (Monday, Tuesday, Wednesday).
After a 4-day washout period, they then received placebo of chocolate cookies and consumed them over three days.
|
225mg mixed powdered Artificial Food Coloring (AFC)
Placebo chocolate cookies
|
|
Experimental: Controls - Placebo, then artificial food coloring
Participants first received placebo of chocolate cookies and consumed them over three days.
After a 4-day washout period, they then received 225 mg of the six most common artificial food colors (Red 40, Red 3, Yellow 5, Yellow 6, Blue 1, and Blue 2) mixed in chocolate cookies and consumed consecutively over three days (Monday, Tuesday, Wednesday).
|
225mg mixed powdered Artificial Food Coloring (AFC)
Placebo chocolate cookies
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean Power (EEG) During AFC and Placebo Challenge in ADHD and Control Groups
Time Frame: Collected after three days exposure to AFC (on third day) and after three day exposure to placebo (on third day)
|
Electroencephalography (EEG) is an objective measure of brainwave activity that non-invasively records the electrocortical activity emitted from neuronal postsynaptic outputs using small electrodes placed on the head. Quantitative EEG uses techniques to transform electrocortical voltage amplitudes into frequency bands to reflect mental processes in periodicities instead of raw values. These frequency bands can then be compared before/after treatment and/or between groups to better understand how treatment impacts the brain. Resting-state EEG was collected with eyes-closed, but awake, for four minutes Frequency bands assessed: delta 1-4Hz, theta 4-7Hz, alpha 8-13Hz, beta 13-30Hz, gamma 30-50Hz Each frequency band was assessed using: mean power (microvolts^2 of a frequency band divided by the length of the frequency band) a |
Collected after three days exposure to AFC (on third day) and after three day exposure to placebo (on third day)
|
|
Relative Power (EEG) During AFC and Placebo Challenge in ADHD and Control Groups
Time Frame: Collected after three days exposure to AFC (on third day) and after three day exposure to placebo (on third day)
|
Electroencephalography (EEG) is an objective measure of brainwave activity that non-invasively records the electrocortical activity emitted from neuronal postsynaptic outputs using small electrodes placed on the head. Quantitative EEG uses techniques to transform electrocortical voltage amplitudes into frequency bands to reflect mental processes in periodicities instead of raw values. These frequency bands can then be compared before/after treatment and/or between groups to better understand how treatment impacts the brain. Resting-state EEG was collected with eyes-closed, but awake, for four minutes Frequency bands assessed: delta 1-4Hz, theta 4-7Hz, alpha 8-13Hz, beta 13-30Hz, gamma 30-50Hz Each frequency band was assessed using: relative power (sum of microvolts^2 of a frequency band divided by total power to get a percent) |
Collected after three days exposure to AFC (on third day) and after three day exposure to placebo (on third day)
|
|
ADHD Symptoms During AFC and Placebo Challenge in ADHD and Control Groups
Time Frame: Collected after three days exposure to AFC (on third day) and after three day exposure to placebo (on third day)
|
Name: Adult ADHD Self-Report Scale-V1.1 Construct: Self-report checklist of adult ADHD symptoms to screen for possibility of ADHD. It is not meant to be diagnostic. According to the documentation, "The questions in the ASRS v1.1 are consistent with DSM-IV criteria and address the manifestations of ADHD symptoms in adults." Total Range: 0-72 points - higher score indicates more and/or higher frequency of adult ADHD symptoms Sub-scores:
|
Collected after three days exposure to AFC (on third day) and after three day exposure to placebo (on third day)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kathleen Holton, PhD, American University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-2017-151
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Hyperactivity Disorder
-
King's College LondonActive, not recruitingAttention-Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder SymptomsUnited Kingdom
-
Cingulate TherapeuticsSuspendedPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Cingulate TherapeuticsPremier Research Group plcCompletedADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Central South UniversityRecruitingAttention-Deficit/Hyperactivity DisorderChina
-
Universidade do Sul de Santa CatarinaAssociação Brasileira de Cannabis MedicinalRecruitingAttention-Deficit/Hyperactivity Disorder (ADHD)Brazil
-
Nanjing Medical UniversityRecruitingAdult Attention Deficit Hyperactivity DisorderChina
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research Institute; Children's Hospital of Philadelphia and other collaboratorsNot yet recruitingAttention-Deficit/Hyperactivity Disorder (ADHD)United States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Disorder With HyperactivityUnited States
-
Qbtech ABEnrolling by invitationAttention Deficit Disorder With Hyperactivity (ADHD) | Attention Deficit Disorder (ADD)United States
Clinical Trials on Artificial Food Coloring
-
Çanakkale Onsekiz Mart UniversityCompletedMother-Infant BondingTurkey (Türkiye)
-
Nuh Naci Yazgan UniversityTC Erciyes University; Kayseri City HospitalNot yet recruitingPostpartum | Mandala ColoringTurkey (Türkiye)
-
Karamanoğlu Mehmetbey UniversityCompletedMental Well-being | Life Satisfaction | Mandala ColoringTurkey (Türkiye)
-
Sanko UniversityCompletedHemodialysis Patients | Art Therapy | Mandala PaintingTurkey
-
Maltepe UniversityCompletedNursing Caries | Art TherapyTurkey
-
Istanbul Sabahattin Zaim UniversityCompleted
-
Stony Brook UniversityRecruiting
-
Artvin Coruh UniversityRecruitingBreast CancerTurkey (Türkiye)
-
Istanbul Medeniyet UniversityCompletedAnxiety | Parents | Psychological StressTurkey (Türkiye)
-
Atlas UniversityCompletedDialysis | Self Care | SymptomsTurkey